Meyahealth
HomeGeneticsGenePNKD gene
Back to Gene
PNKD gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

PNKD gene

The PNKD gene is highly active in the brain and is believed to play a role in regulating neurotransmitter release and protecting nerve cells from toxic chemicals.

Normal Function

While the exact role of the PNKD gene (frequently called the MR1 gene) is still being researched, it is highly active in the brain, suggesting it is essential for normal brain function. The protein produced may help control the release of neurotransmitters, the chemicals that allow nerve cells (neurons) to communicate.

The PNKD protein is similar to another protein that breaks down methylglyoxal, a chemical found in coffee, tea, cola, and alcoholic beverages that is known to be toxic to neurons. It is hypothesized that the PNKD protein may perform a similar protective function.

Health Conditions Related to Genetic Changes

Familial paroxysmal nonkinesigenic dyskinesia

At least three mutations in the PNKD gene cause familial paroxysmal nonkinesigenic dyskinesia, a condition characterized by episodes of involuntary movement.

  • Common Mutations: The two most common mutations replace the amino acid alanine with valine at position 7 (Ala7Val or A7V) and position 9 (Ala9Val or A9V).
  • Impact: Research suggests these mutations alter the structure of the PNKD protein and interfere with its ability to function.
  • Clinical Presentation: While the link between these mutations and the resulting involuntary movements is not fully understood, the gene's role in synaptic function and stress response is a primary area of study.

Genomic Location

The PNKD gene is found on chromosome 2.

Frequently Asked Questions

definitive diagnosis requires sequencing of the PNKD gene to identify pathogenic variants, most commonly Ala7Val or Ala9Val. Genetic counseling is recommended for family members, as the condition is autosomal dominant with variable expressivity.
While no drug is specifically approved for PNKD, some patients benefit from low‑dose antiepileptic drugs such as levetiracetam or valproate, which can dampen neuronal excitability. Dopamine‑modulating agents have limited evidence, and treatment is usually tailored to individual response.
Episodes are often precipitated by stress, fatigue, alcohol consumption, or certain medications such as antipsychotics. Managing triggers involves maintaining a regular sleep schedule, avoiding alcohol, and using stress‑reduction techniques. If an episode starts, a short course of benzodiazepines (e.g., clonazepam) can sometimes abort the attack.
Most patients retain normal cognition, but some may experience mild speech or coordination difficulties during or after episodes. Routine neurological exams and, if indicated, neuropsychological testing can monitor for subtle changes. Regular follow‑up with a movement disorder specialist helps adjust therapy and assess long‑term outcomes.===
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ